Living with Lobular Breast Cancer in Canada(@lobbccanada) 's Twitter Profileg
Living with Lobular Breast Cancer in Canada

@lobbccanada

C. McKay, MSW, lobular breast cancer advocate and researcher, dx. 2013, lobular bc skin recurrences x4. Interested in policy, politics and practice.

ID:2258205164

calendar_today22-12-2013 22:55:01

10,0K Tweets

644 Followers

1,0K Following

Jean Seely, MD(@JeanSeely) 's Twitter Profile Photo

Astounding and disturbing results Canadian Society of Breast Imaging uOttawa Dept. Radiology, Rad Onc & Medical Physics Incidence of Breast Cancer in Younger Women: A Canadian Trend Analysis - Jean M. Seely, Larry F. Ellison, Jean-Michel Billette, Shary X. Zhang, Anna N. Wilkinson, 2024 journals.sagepub.com/doi/full/10.11…

Astounding and disturbing results @CanadaSBI @uOttawaRad Incidence of Breast Cancer in Younger Women: A Canadian Trend Analysis - Jean M. Seely, Larry F. Ellison, Jean-Michel Billette, Shary X. Zhang, Anna N. Wilkinson, 2024 journals.sagepub.com/doi/full/10.11…
account_circle
Research at Canadian Cancer Society(@CCSResearch) 's Twitter Profile Photo

Presentation by Rebecca Auer, MD about their Breakthrough project to expand access to clinical trials and personalized treatments for people with biliary tract cancers, accelerating progress and providing hope to people with this devastating disease.

Presentation by @auer_r about their Breakthrough project to expand access to clinical trials and personalized treatments for people with biliary tract cancers, accelerating progress and providing hope to people with this devastating disease.
account_circle
Anna Wilkinson(@Anwilkinson) 's Twitter Profile Photo

Breast cancer rates increasing significantly in younger women in Canada. In the last 35 years:
➡️45.5% in 20-29
➡️12.5% in 30-39
➡️9.1% in 40-49
➡️17.5% in 50-54
uOttawa - Médecine familiale, Family Medicine Statistics Canada Marina von Stackelberg

account_circle
Cholangiocarcinoma Foundation(@curecc) 's Twitter Profile Photo

Thank you, WCVB Boston News, for sharing this story about the hope in research.

Special thanks to Dave Fleischer and Lane Kelleher for graciously sharing their experiences caring for their family members.

wcvb.com/article/resear…

account_circle
Elizabeth Snouffer(@ElizabethType1) 's Twitter Profile Photo

Lilly's message to shareholders before May 2024 annual meeting. It's important investors know that JDRF is paid to behave. 🤣 investor.lilly.com/node/50556/html

Lilly's message to shareholders before May 2024 annual meeting. It's important investors know that JDRF is paid to behave. 🤣 #insulinshortage #type1diabetes investor.lilly.com/node/50556/html
account_circle
Lori Petitti(@hiplinemedia) 's Twitter Profile Photo

Well heck, we all need this! Register for an The National Institute on Aging (NIA) - NCI Cancer Control webinar on June 20 at 11 a.m. ET to hear speakers discuss the assessment of epigenetic aging in post-treatment cancer survivors. go.nih.gov/8OD9cHO Wilmot Cancer Institute

account_circle
DrWendieBerg(@DrWendieBerg) 's Twitter Profile Photo

Updated EUSOBI guidelines add screening US or MRI in average-risk women with dense breasts, MRI at least q4 years if extremely dense; endorse breast cancer risk assessment at age 25, as American College of Radiology. High-risk women annual MRI at 25, depending on risk. DenseBreast-Info.org

Updated @EUSOBIyc guidelines add screening US or MRI in average-risk women with dense breasts, MRI at least q4 years if extremely dense; endorse breast cancer risk assessment at age 25, as @RadiologyACR. High-risk women annual MRI at 25, depending on risk. @DenseBreastInfo
account_circle
Marathon of Hope Cancer Centres Network(@marathonofhope) 's Twitter Profile Photo

Precision oncology has shown promising results, but it's still not available to all patients.

Before we broaden access to it, we need evidence to help decision makers determine how it should be deployed in a context where healthcare resources are scarce. (1/2)

Precision oncology has shown promising results, but it's still not available to all patients. Before we broaden access to it, we need evidence to help decision makers determine how it should be deployed in a context where healthcare resources are scarce. (1/2)
account_circle
Deb Maes❤️🧡💙(@deb_maes61) 's Twitter Profile Photo

Saw oncologist yesterday on to new meds but have to be approved for funding ( yes here in Canada too) . These drugs cost up to 6000 per month so hope funding comes through for me . Hope to hear Tuesday ic collar of shame can come off n soon when rad start .

account_circle
Darlaine honey(@darlaine_honey) 's Twitter Profile Photo

There also needs to be more understanding and help with better imaging for . Due to its single cell MO,(lacking e cadherin)metastis often not seen in other areas of the body. We dont even get MRI for breast follow up, even when mammo didnt spot the original cancer.

account_circle
Julia Maués(@itsnot_pink) 's Twitter Profile Photo

“Breast cancer is preventable.”

One of the worst things one can tell people with cancer.

What is that saying about those who have a diagnosis? And those who died of cancer?

account_circle
Angus Pratt 🇨🇦(@anguspratt) 's Twitter Profile Photo

It has been an absolutely incredible two days of amazing world class research. And this is just the beginning of a five year run!

account_circle
sue robins (she/her)(@suerobinsyvr) 's Twitter Profile Photo

You know what needs a big overhaul?

Health conferences.

They've regressed big-time since 2020.

Back to being elite events, flying in big-name speakers giving canned talks, in-person only, little patient representation. /1

account_circle
CBCN(@CBCN) 's Twitter Profile Photo

Cryoablation for breast cancer is being introduced for eligible patients for the first time in a Montreal hospital. Cryoablation is a process whereby a tumour is frozen using an ultrafine needle. It is minimally invasive and is performed as a day surgery
buff.ly/3UxukV7

account_circle
Research at Canadian Cancer Society(@CCSResearch) 's Twitter Profile Photo

Presentation by gelareh-zadeh, Andrew Ajisebutu, Shreya Gandhi, Sheila Mansouri and Stephen Yip, MD/PhD FRCPC about their Breakthrough project to develop a non-invasive technique to improve outcomes for people with brain cancer through better diagnosis, monitoring of treatment and prediction.

Presentation by @gelarehzadeh, @AndrewAjisebutu, @shreya_gandhi2, @MansouriSheila and @Sty_md about their Breakthrough project to develop a non-invasive technique to improve outcomes for people with brain cancer through better diagnosis, monitoring of treatment and prediction.
account_circle
Martha Lincoln(@heavyredaction) 's Twitter Profile Photo

“They’ll say we’re disturbing the peace, but there is no peace. What really bothers them is that we are disturbing the war.” Howard Zinn 1971

account_circle
IPOS(@IPOSPsychoOncol) 's Twitter Profile Photo

Special LMIC Collection launched at IPOS’ official journal: The Journal of Psychosocial Oncology Research and Practice - a special initiative to support the publication of psycho-oncology research from LMICs through our official journal

Read more ipos-society.org/News/13348177

Special LMIC Collection launched at IPOS’ official journal: The Journal of Psychosocial Oncology Research and Practice - a special initiative to support the publication of psycho-oncology research from LMICs through our official journal Read more ipos-society.org/News/13348177
account_circle
Antonio Giordano, MD PhD(@antgiorda) 's Twitter Profile Photo

The limbo of having ER/PR low (<10%) is currently a very important problem for trial enrollment
ER 0 PR 5% HER2 0
1⃣cannot be enrolled in HR+ cohorts if have not received CDK4/6i
2⃣cannot be enrolled in TNBC cohort because ASCO/CAP guidelines
FDA Oncology relax I/E cr

account_circle